Video

Raising Funds for Brain Tumors Until Poof! They Disappear

Author(s):

Thea's Star of Hope

When asked about her favorite thing about Thea's Star of Hope, the ten-year-old explained that the organization is like a laser on pediatric brain tumors, shooting at them until, hopefully one day, poof! They disappear.

When Thea Danze was four months old, she was diagnosed with a brain tumor. So, in 2011, her mother, Trisha, started a nonprofit called Thea's Star of Hope that raises funds for pediatric brain tumor research, with hopes of finding treatments that are more effective and less toxic.

CURE invited Trisha, Thea and Thea's younger sister, Lilly, to our video studio to learn more about the organization.

When asked about her favorite thing about Thea's Star of Hope, the ten-year-old explained that the organization is like a laser on pediatric brain tumors, shooting at them until, hopefully one day, poof! They disappear.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman, with text.
Image of woman with text.
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Image of woman with text.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Related Content
After surviving brain surgery, I found clarity, strength, and unexpected joy: © stock.adobe.com.
July 26th 2025

A Little Off the Top: the First Step in a Brain Cancer Journey

Bren Ohta, PhD, MS, LCSW
After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not the diagnosis.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of brain.
July 22nd 2025

My Invisible Illness: Living With Brain Fog After Brain Tumor Surgery

Kristen Stewart
Even six years after brain tumor surgery, invisible symptoms like brain fog and memory loss shape how I live, cope, and find gratitude every day.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of clinical trial.
July 7th 2025

New Trials Target Brain, Bladder, Ovarian and Other Cancers

Spencer Feldman
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.
Image of brain tumor.
July 7th 2025

FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas

Spencer Feldman
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.